Ascend Wellness Holdings (AAWH) Total Debt Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -13.33% |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn | -9.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.29% |
| Dec 31, 2025 | -13.35% |
| Sep 30, 2025 | 20.64% |
| Jun 30, 2025 | 13.03% |
| Mar 31, 2025 | 7.25% |
| Dec 31, 2024 | 24.55% |
| Sep 30, 2024 | -0.49% |
| Jun 30, 2024 | -0.16% |
| Mar 31, 2024 | -4.17% |
| Dec 31, 2023 | -7.55% |
| Sep 30, 2023 | -0.97% |
| Jun 30, 2023 | 5.63% |
| Mar 31, 2023 | 38.66% |
| Dec 31, 2022 | 27.76% |
| Sep 30, 2022 | 21.47% |
| Jun 30, 2022 | 127.73% |
| Mar 31, 2022 | -6.23% |
| Dec 31, 2021 | 22.30% |